Based on this evidence, the anemia guidelines of the Kidney Disease Outcomes Quality Initiative (KDOQI), which were updated in 2007, recommended an upper target of 12 g/dL for Hb and suggested that Hb levels should not exceed 13 g/dL [17]. The gene discussed is GSTM1; the disease is anemia.